Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89,506,929
-
Total 13F shares
-
31,068,273
-
Share change
-
+13,272,156
-
Total reported value
-
$55,610,121
-
Put/Call ratio
-
106%
-
Price per share
-
$1.79
-
Number of holders
-
40
-
Value change
-
+$23,911,141
-
Number of buys
-
22
-
Number of sells
-
14
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Stock (MIST) as of Q1 2024
As of 31 Mar 2024,
Milestone Pharmaceuticals Inc. - Common Stock (MIST) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,068,273 shares.
The largest 10 holders included
BlackRock Inc., RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, Alta Fundamental Advisers LLC, Lion Point Capital, LP, CITADEL ADVISORS LLC, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.